Company
Matisse Pharmaceuticals
Developing the solution to treat life-threatening inflammation
- Business model
- B2B
- Legal name
- Matisse Pharmaceuticals B.V.
Record updated 28 September 2026
About
Matisse Pharmaceuticals BV is a biopharmaceutical clinical stage company dedicated to develop a product portfolio of safe and innovative therapies for disease indications characterized by elevated levels of freely circulating cytotoxic histones, such as in sepsis and septic shock.
Products
- Web
- isupartob sodium